Pharmacological approaches to the correction of autonomic dysfunction in patients with hypertension
- 14 October 2026
- journal article
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 29 (9)
Abstract
Hypertension is a major contributor to global cardiovascular morbidity and mortality. The autonomic nervous system is essential to homeostasis, and its dysfunction, present in 65—85% of hypertension cases, contributes to cognitive and psycho-autonomic disorders. Objective. To assess the efficacy and safety of sequential therapy with ethyl methylhydroxypyridine succinate (Mexidol, solution for injections and 125 mg tablets) in patients with autonomic dysfunction associated with hypertension. Materials and methods. This prospective, open-label, comparative study enrolled 60 patients aged 40 to 59 years with stage I—II hypertension and autonomic dysfunction (A.M. Vein score >15). The main group (n=30) received standard antihypertensive therapy plus ethyl methylhydroxypyridine succinate, administered intramuscularly for 10 days at 4.0 mL (200 mg), followed by oral administration of 125 mg three times daily for 8 weeks. The control group (n=30) received only standard therapy. Assessments included the A.M. Vein scale, Schulte test, Digital Symbol Substitution Test (DSST), 5-word test, Hospital Anxiety and Depression Scale (HADS), and Clinical Global Impression (CGI). Results. The main group exhibited a statistically significant reduction in the A.M. Vein score by the second visit (p<0.001), followed by further reduction at the third visit (p<0.001). Significant improvements in executive function, as measured by the DSST (p<0.001), and in early memory consolidation, as assessed by the 5-word test (p<0.001), were observed. The HADS scale demonstrated a pronounced anxiolytic and antidepressant effect (p<0.001). According to the CGI scale, improvement at the end of follow-up was observed in 69.5% of patients in the main group, compared to 0% in the control group (p<0.001). Conclusions. Sequential therapy with ethyl methylhydroxypyridine succinate (solution and tablets) is an effective and safe strategy for correcting autonomic, cognitive, and affective disorders in patients with hypertension and autonomic dysfunction.Keywords
This publication has 19 references indexed in Scilit:
- Interim analysis of prospective observational multicenter study of patients with hypertension and chronic kidney disease in the Russian Federation (PRIORITY-CKD)Russian Journal of Cardiology, 2025
- 2024 Clinical practice guidelines for Hypertension in adultsRussian Journal of Cardiology, 2024
- Neurometabolic therapy of mild cognitive impairment in patients with chronic cerebral ischemiaS.S. Korsakov Journal of Neurology and Psychiatry, 2024
- Improving the effectiveness of pharmacotherapy in comorbid patients with chronic cerebral ischemia on an outpatient basisS.S. Korsakov Journal of Neurology and Psychiatry, 2023
- 2022 Prevention of chronic non-communicable diseases in Of the Russian Federation. National guidelinesCardiovascular Therapy and Prevention, 2022
- Therapy of moderate cognitive impairment and asthenia in patients with cerebrovascular pathology: results of a prospective observational studyS.S. Korsakov Journal of Neurology and Psychiatry, 2022
- Sympathetic hyperactivity in patients with hypertension: pathogenesis and treatment. Part ICardiovascular Therapy and Prevention, 2020
- Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA)S.S. Korsakov Journal of Neurology and Psychiatry, 2017
- Arterial hypertension and stroke: cardiac and neurological aspects of secondary preventionNeurology, Neuropsychiatry, Psychosomatics, 2014
- Autonomic nervous system in arterial hypertension and heart failure: current understanding of its pathophysiologic role and innovative treatment approachesRussian Journal of Cardiology, 2013